MedTrace Logo

A Single-Center Open-Label Study of 1064 nm for Nonablative Skin Rejuvenation

NCT03421691 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2023-09-06

Study results available
· View outcomes & findings →

Summary

The purpose of this investigation is to evaluate the safety and efficacy of the Cutera excel V Laser Genesis procedure utilizing the 1064nm laser for skin rejuvenation.

Conditions

  • Skin Pigment
  • Photoaging

Interventions

DEVICE

excel V Laser

excel V Laser Genesis procedure utilizing 1064 nm laser

Sponsors & Collaborators

  • Cutera Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-15
Primary Completion
2018-02-07
Completion
2018-02-07
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03421691 on ClinicalTrials.gov